Pure And Cure Healthcare Pvt Ltd
⚠️ High Risk
FEI: 3011558880 • Haridwar, Uttaranchal • INDIA
FEI Number
3011558880
Location
Haridwar, Uttaranchal
Country
INDIAAddress
Plot 27-30 Sector 8A, IIE Sidcul, Haridwar, Uttaranchal, India
High Risk
FDA Import Risk Assessment
This firm has a significant history of FDA import refusals with notable violations.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
UNAPPROVED
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).
NOT LISTED
It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).
FRNMFGREG
The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded as defined in section 502(o) of the FD&C Act. It appears that it was manufactured, prepared, propagated, compounded, or processed in an establishment not duly registered under section 510 of the Act.
Refusal History
| Date | Product | Violations | Division |
|---|---|---|---|
| 5/23/2025 | 61FDY54CIPROFLOXACIN (ANTI-BACTERIAL PART I) (NOT ANTIBIOTIC) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 4/11/2025 | 61PCY99ANTI-DIABETIC N.E.C. | Division of Southeast Imports (DSEI) | |
| 3/3/2025 | 62GDY99ANTI-INFLAMMATORY N.E.C. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 1/31/2025 | 61TDY31DOMPERIDONE | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 7/17/2024 | 56ODY02MOXIFLOXACIN HCL (FLUOROQUINOLONE) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 4/22/2024 | 61EDA06FEXOFENADINE HCL (ANTI-ASTHMATIC) | Division of Southeast Imports (DSEI) | |
| 2/13/2024 | 62GDA48MEFENAMIC ACID (ANTI-INFLAMMATORY) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 11/20/2020 | 61TDY31DOMPERIDONE | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 10/2/2020 | 62ODA05RAMIPRIL (ANTI-HYPERTENSIVE - PART II) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 9/4/2020 | 66VCA99MISCELLANEOUS PATENT MEDICINES, ETC. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 8/5/2020 | 61TDA31DOMPERIDONE | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 1/30/2019 | 62GDY49NAPROXEN (ANTI-INFLAMMATORY) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
Frequently Asked Questions
What is Pure And Cure Healthcare Pvt Ltd's FDA import refusal history?
Pure And Cure Healthcare Pvt Ltd (FEI: 3011558880) has 12 FDA import refusal record(s) in our database, spanning from 1/30/2019 to 5/23/2025.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Pure And Cure Healthcare Pvt Ltd's FEI number is 3011558880.
What types of violations has Pure And Cure Healthcare Pvt Ltd received?
Pure And Cure Healthcare Pvt Ltd has been cited for 3 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about Pure And Cure Healthcare Pvt Ltd come from?
All FDA import refusal data for Pure And Cure Healthcare Pvt Ltd is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.